The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Protasova A.E.

Saint-Petersburg State University;
North-Western State Medical University named after I.I. Mechnikov;
V.A. Almazov National Medical Research Center;
AVA-PETER LLC.

Andreeva E.N.

Endocrinology Research Centre Russia;
FSBEI HE «Russian University of Medicine" Ministry of Health of Russia

Tapilskaya N.I.

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproduction;
Saint-Petersburg State Pediatric Medical University

Adamyan L.V.

Russian University of Medicine;
National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov

Combined oral contraception and breast. Aspects of truth

Authors:

Protasova A.E., Andreeva E.N., Tapilskaya N.I., Adamyan L.V.

More about the authors

Journal: Russian Journal of Human Reproduction. 2024;30(4): 101‑105

Read: 1630 times


To cite this article:

Protasova AE, Andreeva EN, Tapilskaya NI, Adamyan LV. Combined oral contraception and breast. Aspects of truth. Russian Journal of Human Reproduction. 2024;30(4):101‑105. (In Russ.)
https://doi.org/10.17116/repro202430041101

Recommended articles:
Immu­nology of the cervix in normal and pathological conditions (literature review). Russian Journal of Human Reproduction. 2024;(5):108-117
Analysis of medi­cal preventive stru­ctures staff resources in 2023. Russian Journal of Preventive Medi­cine. 2024;(10):45-51
Study of opinions of medi­cal students on medi­cal prevention issues. Russian Journal of Preventive Medi­cine. 2024;(12):69-74
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114

References:

  1. Vendramin R, Litchfield K, Swanton C. Cancer evolution: Darwin and beyond. The EMBO Journal. 2021;40(18):e108389. https://doi.org/10.15252/embj.2021108389
  2. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer. 1961;14:1272-1294. https://doi.org/10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h
  3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: a Cancer Journal for Clinicians. 2022;72(1):7-33.  https://doi.org/10.3322/caac.21708
  4. Dobbs R, Sawers C, Thompson F, Manyika J, Woetzel J, Child P, McKenna S, Spatharou A. Overcoming obesity: An initial economic analysis [Internet]. McKinsey Global Institute; 2014. Accessed June 14, 2024. https://www.mckinsey.com/~/media/mckinsey/business%20functions/economic%20studies%20temp/our%20insights/how%20the%20world%20could%20better%20fight%20obesity/mgi_overcoming_obesity_full_report.pdf
  5. Ahluwalia MK. Chrononutrition — When We Eat Is of the Essence in Tackling Obesity. Nutrients. 2022;14(23):5080. https://doi.org/10.3390/nu14235080
  6. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;136(5):E359-E386. https://doi.org/10.1002/ijc.29210
  7. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa S. NCCN Guidelines Insights: Cervical Cancer, Version 1.2024. Journal of the National Comprehensive Cancer Network : JNCCN. 2023;21(12):1224-1233. https://doi.org/10.6004/jnccn.2023.0062
  8. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O’Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benítez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB; HEBON; Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C; EMBRACE; Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schönbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L; GEMO Study Collaborators; Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Cañadas C, Heikkinen T, Heikkilä P, Aittomäki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D’Andrea E, Yan M, Fox S; kConFab Investigators; Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K; SWE-BRCA Collaborators; Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC. Consortium of Investigators of Modifiers of BRCA1/2. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology, Biomarkers and Prevention. 2012;21(1):134-147.  https://doi.org/10.1158/1055-9965.EPI-11-0775
  9. Bosson-Amedenu S, Acquah J, Nyarko CC, Ouerfelli N. A Novel Three Parameter Modified Cox Frailty Model for Noncompeting Risk Patients with Breast Cancer Malignality. Mathematical Theory and Modeling. 2022;12(1):1-15. 
  10. Peduzzi G, Archibugi L, Katzke V, Gentiluomo M, Capurso G, Milanetto AC, Gazouli M, Goetz M, Brenner H, Vermeulen RCH, Talar-Wojnarowska R, Vanella G, Tavano F, Lucchesi M, Mohelnikova-Duchonova B, Chen X, Kiudelis V, Hegyi P, Oliverius M, Stocker H, Stornello C, Vodickova L, Souček P, Neoptolemos JP, Testoni SGG, Morelli L, Lawlor RT, Basso D, Izbicki JR, Ermini S, Kupcinskas J, Pezzilli R, Boggi U, van Laarhoven HWM, Szentesi A, Erőss B, Capretti G, Schöttker B, Skieceviciene J, Aoki MN, van Eijck CHJ, Cavestro GM, Canzian F, Campa D. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. Scientific Reports. 2022;12(1):18100. https://doi.org/10.1038/s41598-022-22973-9
  11. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347(9017):1713-1727. https://doi.org/10.1016/s0140-6736(96)90806-5
  12. Medical Eligibility Criteria for Contraceptive Use. 2015. Accessed on March, 07, 2024. https://apps.who.int/iris/bitstream/handle/10665/181468/9789241549158_eng.pdf
  13. Nacional’nye medicinskie kriterii priemlemosti metodov kontracepcii. Adaptirovannyj dokument «Medicinskie kriterii priemlemosti ispol’zovaniya metodov kontracepcii VOZ, 5 izdanie, 2015». Pod red. Suhih G.T., Prilepskoj V.N. M. 2023. (In Russ.).
  14. Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR. Recommendations and Reports: Morbidity and mortality weekly report. Recommendations and Reports. 2016;65(3):1-103.  https://doi.org/10.15585/mmwr.rr6503a1
  15. Santen RJ, Mansel R. Benign breast disorders. The New England Journal of Medicine. 2005;353(3):275-285.  https://doi.org/10.1056/NEJMra035692
  16. Mammologiya: nacional’noe rukovodstvo. Pod red. A.D. Kaprina, N.I. Rozhkovoj. 2-e izd., pererab. i dop. M.: GEOTAR-Media; 2016. (In Russ.).
  17. Leonidova TN, Mikova VN. Hormonal contraception and risks for breast disorders. Doktor.ru. 2016;3(120):15-17. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.